BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Científica da Faculdade de Medicina de Campos |
Texto Completo: | https://www.fmc.br/ojs/index.php/RCFMC/article/view/405 |
Resumo: | The objective of this work is to know the Pediatric Multi-Systemic Inflammatory Syndrome associated to COVID-19 and to alert health professionals about the importance of early diagnosis and conducts. The COVID-19 is a highly contagious disease that has rapidly become a global public health problem. Since the beginning of the pandemic, the elderly and people with comorbidities are part of the risk group. While children are usually asymptomatic and more concerned about being considered a reservoir of the virus, they can transmit it to other people. However, recently, infantile cases have been reported that have had an unfavorable evolution. Pediatric Multi-Systemic Inflammatory Syndrome associated with COVID-19 was first reported in Europe as a disease occurring weeks after the acute phase of SARS-COV-2 infection. The clinical manifestations and laboratory characteristics of this disease are similar to other inflammatory diseases present in pediatrics such as typical Kawasaki syndrome, incomplete Kawasaki, toxic shock syndrome, bacterial sepsis and macrophage activation syndrome. Differently from what is observed in other inflammatory diseases, the SIM-P affects preferentially children older than 5 years, afro-descendants, besides presenting a higher incidence of cardiac dysfunction. The treatment must involve multidisciplinary actions and be early in order to minimize the sequelae, especially cardiac and thus reduce mortality. |
id |
FMC-0_02720e23b03afddc3fef0d9b77f4ff82 |
---|---|
oai_identifier_str |
oai:ojs.www.fmc.br:article/405 |
network_acronym_str |
FMC-0 |
network_name_str |
Revista Científica da Faculdade de Medicina de Campos |
repository_id_str |
|
spelling |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19REVISÃO BIBLIOGRÁFICA: SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA ASSOCIADA AO COVID-19CoronavírusSíndrome InflamatóriaPediatriaCoronavirusInflammatory SyndromePediatricsThe objective of this work is to know the Pediatric Multi-Systemic Inflammatory Syndrome associated to COVID-19 and to alert health professionals about the importance of early diagnosis and conducts. The COVID-19 is a highly contagious disease that has rapidly become a global public health problem. Since the beginning of the pandemic, the elderly and people with comorbidities are part of the risk group. While children are usually asymptomatic and more concerned about being considered a reservoir of the virus, they can transmit it to other people. However, recently, infantile cases have been reported that have had an unfavorable evolution. Pediatric Multi-Systemic Inflammatory Syndrome associated with COVID-19 was first reported in Europe as a disease occurring weeks after the acute phase of SARS-COV-2 infection. The clinical manifestations and laboratory characteristics of this disease are similar to other inflammatory diseases present in pediatrics such as typical Kawasaki syndrome, incomplete Kawasaki, toxic shock syndrome, bacterial sepsis and macrophage activation syndrome. Differently from what is observed in other inflammatory diseases, the SIM-P affects preferentially children older than 5 years, afro-descendants, besides presenting a higher incidence of cardiac dysfunction. The treatment must involve multidisciplinary actions and be early in order to minimize the sequelae, especially cardiac and thus reduce mortality.O objetivo deste trabalho é conhecer a Síndrome Inflamatória Multissistêmica Pediátrica associada ao COVID-19 (SIM-P) e alertar profissionais de saúde sobre a importância do diagnóstico e condutas precoces. Esse estudo trata-se de uma revisão integrativa de literatura, utilizando artigos nacionais e internacionais dos seguintes bancos de dados: PUBMED, SciELO e Clinicalkey. Sabe-se que a COVID-19 é uma doença altamente contagiosa que rapidamente se tornou um problema de saúde pública mundial. Desde o início da pandemia, os idosos e portadores de comorbidades fazem parte do grupo de risco. Enquanto, as crianças, normalmente, são assintomáticas e preocupam mais pelo fato serem consideradas um reservatório do vírus, podendo transmiti-lo. No entanto, recentemente, foram notificados casos infantis que tiveram uma evolução atípica. A Síndrome Inflamatória Multissistêmica Pediátrica associada ao COVID-19 foi relatada pela primeira vez na Europa como uma doença que ocorre semanas após a fase aguda da infecção pelo SARS-COV-2. As manifestações clínicas e as características laboratoriais dessa doença são semelhantes a outras doenças inflamatórias presentes na pediatria como a Síndrome de Kawasaki típica, Kawasaki incompleta, síndrome do choque tóxico, sepse bacteriana e síndrome de ativação macrofágica. Diferentemente do que é observado nas demais doenças inflamatórias, a SIM-P afeta preferencialmente crianças maiores que 5 anos, afrodescendentes, além de apresentar uma maior incidência de disfunção cardíaca. O tratamento deve envolver ações multidisciplinares e ser precoce a fim de minimizar as complicações associadas a essa patologia, principalmente cardíacas e, assim, diminuir a mortalidade.Faculdade de Medicina de Campos (FMC)2020-12-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/40510.29184/1980-7813.rcfmc.405.vol.15.n3.2020Scientific Journal of the Medical School of Campos; Vol. 15 No. 3 (2020); 77-81Revista Científica da Faculdade de Medicina de Campos; v. 15 n. 3 (2020); 77-811980-7813reponame:Revista Científica da Faculdade de Medicina de Camposinstname:Faculdade de Medicina de Campos (FMC)instacron:FMCporhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/405/237Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Camposhttps://creativecommons.org/licenses/by-sa/4.0info:eu-repo/semantics/openAccessMartins, Gabriele Maria VianaRangel, Suellen dos SantosEduardo, Mariana PompermayerRosário, Inês Raquel Alves da SilvaDias, Eliane Cristina Casimiro Alves2021-01-25T19:35:01Zoai:ojs.www.fmc.br:article/405Revistahttps://www.fmc.br/ojs/index.php/RCFMC/PRIhttps://www.fmc.br/ojs/index.php/RCFMC/oai||revista@fmc.br1980-78131980-7813opendoar:2021-01-25T19:35:01Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)false |
dc.title.none.fl_str_mv |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 REVISÃO BIBLIOGRÁFICA: SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA ASSOCIADA AO COVID-19 |
title |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 |
spellingShingle |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 Martins, Gabriele Maria Viana Coronavírus Síndrome Inflamatória Pediatria Coronavirus Inflammatory Syndrome Pediatrics |
title_short |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 |
title_full |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 |
title_fullStr |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 |
title_full_unstemmed |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 |
title_sort |
BIBLIOGRAPHIC REVIEW: MULTISISTEMIC PEDIATRIC INFLAMMATORY SYNDROME ASSOCIATED TO COVID-19 |
author |
Martins, Gabriele Maria Viana |
author_facet |
Martins, Gabriele Maria Viana Rangel, Suellen dos Santos Eduardo, Mariana Pompermayer Rosário, Inês Raquel Alves da Silva Dias, Eliane Cristina Casimiro Alves |
author_role |
author |
author2 |
Rangel, Suellen dos Santos Eduardo, Mariana Pompermayer Rosário, Inês Raquel Alves da Silva Dias, Eliane Cristina Casimiro Alves |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Martins, Gabriele Maria Viana Rangel, Suellen dos Santos Eduardo, Mariana Pompermayer Rosário, Inês Raquel Alves da Silva Dias, Eliane Cristina Casimiro Alves |
dc.subject.por.fl_str_mv |
Coronavírus Síndrome Inflamatória Pediatria Coronavirus Inflammatory Syndrome Pediatrics |
topic |
Coronavírus Síndrome Inflamatória Pediatria Coronavirus Inflammatory Syndrome Pediatrics |
description |
The objective of this work is to know the Pediatric Multi-Systemic Inflammatory Syndrome associated to COVID-19 and to alert health professionals about the importance of early diagnosis and conducts. The COVID-19 is a highly contagious disease that has rapidly become a global public health problem. Since the beginning of the pandemic, the elderly and people with comorbidities are part of the risk group. While children are usually asymptomatic and more concerned about being considered a reservoir of the virus, they can transmit it to other people. However, recently, infantile cases have been reported that have had an unfavorable evolution. Pediatric Multi-Systemic Inflammatory Syndrome associated with COVID-19 was first reported in Europe as a disease occurring weeks after the acute phase of SARS-COV-2 infection. The clinical manifestations and laboratory characteristics of this disease are similar to other inflammatory diseases present in pediatrics such as typical Kawasaki syndrome, incomplete Kawasaki, toxic shock syndrome, bacterial sepsis and macrophage activation syndrome. Differently from what is observed in other inflammatory diseases, the SIM-P affects preferentially children older than 5 years, afro-descendants, besides presenting a higher incidence of cardiac dysfunction. The treatment must involve multidisciplinary actions and be early in order to minimize the sequelae, especially cardiac and thus reduce mortality. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-21 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/405 10.29184/1980-7813.rcfmc.405.vol.15.n3.2020 |
url |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/405 |
identifier_str_mv |
10.29184/1980-7813.rcfmc.405.vol.15.n3.2020 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/405/237 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
dc.source.none.fl_str_mv |
Scientific Journal of the Medical School of Campos; Vol. 15 No. 3 (2020); 77-81 Revista Científica da Faculdade de Medicina de Campos; v. 15 n. 3 (2020); 77-81 1980-7813 reponame:Revista Científica da Faculdade de Medicina de Campos instname:Faculdade de Medicina de Campos (FMC) instacron:FMC |
instname_str |
Faculdade de Medicina de Campos (FMC) |
instacron_str |
FMC |
institution |
FMC |
reponame_str |
Revista Científica da Faculdade de Medicina de Campos |
collection |
Revista Científica da Faculdade de Medicina de Campos |
repository.name.fl_str_mv |
Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC) |
repository.mail.fl_str_mv |
||revista@fmc.br |
_version_ |
1798042302037360640 |